Abstract:Significance Development of therapeutic strategies for Parkinson’s disease (PD) is hampered by the lack of reliable biomarkers to identify patients at early stages of the disease and track the therapeutic effect of potential drugs and neuroprotective agents. Readily accessible biomarkers capable of providing information about disease status are expected to accelerate this progress. We identified hepatocyte nuclear factor (HNF4A) and polypyrimidine tract binding protein 1 (PTBP1) mRNAs as promising blood biomarkers for identifying early stage PD patients with high diagnostic accuracy. Furthermore, HNF4A was identified as a potential biomarker to monitor disease severity. Longitudinal analysis demonstrated that HNF4A and PTBP1 are longitudinally dynamic biomarkers that provide insights into the molecular mechanisms underlying the altered insulin signaling in PD patients and may enable novel therapeutic strategies. Environmental and genetic factors are likely to be involved in the pathogenesis of Parkinson’s disease (PD), the second most prevalent neurodegenerative disease among the elderly. Network-based metaanalysis of four independent microarray studies identified the hepatocyte nuclear factor 4 alpha (HNF4A), a transcription factor associated with gluconeogenesis and diabetes, as a central regulatory hub gene up-regulated in blood of PD patients. In parallel, the polypyrimidine tract binding protein 1 (PTBP1), involved in the stabilization and mRNA translation of insulin, was identified as the most down-regulated gene. Quantitative PCR assays revealed that HNF4A and PTBP1 mRNAs were up- and down-regulated, respectively, in blood of 51 PD patients and 45 controls nested in the Diagnostic and Prognostic Biomarkers for Parkinson’s Disease. These results were confirmed in blood of 50 PD patients compared with 46 healthy controls nested in the Harvard Biomarker Study. Relative abundance of HNF4A mRNA correlated with the Hoehn and Yahr stage at baseline, suggesting its clinical utility to monitor disease severity. Using both markers, PD patients were classified with 90% sensitivity and 80% specificity. Longitudinal performance analysis demonstrated that relative abundance of HNF4A and PTBP1 mRNAs significantly decreased and increased, respectively, in PD patients during the 3-y follow-up period. The inverse regulation of HNF4A and PTBP1 provides a molecular rationale for the altered insulin signaling observed in PD patients. The longitudinally dynamic biomarkers identified in this study may be useful for monitoring disease-modifying therapies for PD.

Conditional centers and medians of a graph

Giant malignant peripheral nerve sheath tumors of the occipital scalp

Neurofibromatosis to neoplasia transition: a rare case report of spindle cell malignant peripheral nerve sheath tumor with literature review

Malignant Proliferative Ependymoma of the Neck with Lymph Node Metastasis: A Case Report.

[Arthroscopic surgery for the treatment of the synovial chondroma of subacromial bursa: two cases report and review].

Malignant peripheral nerve sheath tumor of the cervix in an adolescent with neurofibromatosis type 1: A case report and review of literature

Melanocytic Malignant Peripheral Nerve Sheath Tumor of the Male Breast

Radiation-Induced Intraosseous Malignant Peripheral Nerve Sheath Tumor: A Case Report

A rare case report of malignant peripheral nerve sheath tumor involving both the small bowel and large bowel

A Rare Case Report of Malignant Peripheral Nerve Sheath Tumor in the Infratemporal Fossa

A rapid detection of toxocaral antibodies by dot enzyme-linked immunosorbent assay (dot-ELISA) in dogs.

Completion Thyroidectomy in the Management of Well-Differentiated Thyroid Carcinoma

School-based programmes for the prevention of drinking and driving: issues and results.

Challenges in the management of metastatic gastrointestinal stromal tumor in a patient with neurofibromatosis type 1: a case report

A rare Encounter with Pediatric Malignant Peripheral Nerve Sheath Tumor in Nasal Sinuses and Orbit

Accelerator Possibilities for Low Energy Antiprotons at the Fermi National Accelerator Laboratory

Plexiform Neurofibroma: A Case Report

Fatal abdominal hemorrhage following surgery to remove a retroperitoneal MPNST associated with NF1: A case report

The Multimodality Management of Malignant Peripheral Nerve Sheath Tumours

Giant Retroperitoneal Malignant Peripheral Nerve Sheath Tumor Treated with Multiorgan Resection: a Case Report and Review of the Literature

Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease